Startups
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com.
Each of our employees brings their own unique ideas, approaches and life experiences to AbbVie. This type of diversity creates an eclectic workplace. Our people have the freedom to challenge ideas, take risks and create novel solutions to better meet patient needs. Discoveries are possible at AbbVie because of the environment we’ve designed, one that fosters creativity and rewards innovation.
Fostering a culture of innovation means more than discovering new medicines. It’s about the way we interact with our world and being a good global citizen. It’s about the way we interact with our colleagues, partners and suppliers to build a better business – and a better global community. It’s a commitment we take seriously and one we instill in our people at all levels.
To ensure we walk the talk, AbbVie is dedicated to building stakeholder engagement, transparency, and a work environment that inspires innovation, trust and collaboration.
AbbVie has positions open around the world and we welcome your application via our global job board at www.abbviecareers.com.
Each of our employees brings their own unique ideas, approaches and life experiences to AbbVie. This type of diversity creates an eclectic workplace. Our people have the freedom to challenge ideas, take risks and create novel solutions to better meet patient needs. Discoveries are possible at AbbVie because of the environment we’ve designed, one that fosters creativity and rewards innovation.
Fostering a culture of innovation means more than discovering new medicines. It’s about the way we interact with our world and being a good global citizen. It’s about the way we interact with our colleagues, partners and suppliers to build a better business – and a better global community. It’s a commitment we take seriously and one we instill in our people at all levels.
To ensure we walk the talk, AbbVie is dedicated to building stakeholder engagement, transparency, and a work environment that inspires innovation, trust and collaboration.
AbbVie has positions open around the world and we welcome your application via our global job board at www.abbviecareers.com.
Overview
Location
United States, Illinois, North Chicago
Employees
10001+
Total raised
$27.2M
Founded date
2013
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 19, 2017 | Series B round | $11.7M |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 25, 2018 | Term Sheet — Thursday, January 25 | HIGH TIMES Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop The new funding brings the firm’s fundraising total to $200 million since its inception in 2011, which makes it the largest private ... |
| Jan 24, 2018 | Bonti Raises $15.5M | Newport Beach-based Bonti, a biopharmaceuticals developer developing treatments for musculoskeletal pain, has raised $15.5M in a Series C funding round. The funding was led by City Hill Ventures. Bonti is developing a compound based on the ... |
| Jan 23, 2018 | Bonti Closes $15.5M Series C Funding | Bonti, a Newport Beach, Calif.-based clinical-stage biotechnology company, closed a $15.5m Series C financing. The round was led by City Hill Ventures. In conjunction with this funding and in preparation for the rest of 2018 and beyond, Bon... |
| Apr 20, 2017 | Bonti Raises $11.7M in Series B Financing | Bonti, a Newport Beach, Calif.-based clinical-stage biotechnology company, secured $11.7m in Series B financing. The round was led by RBV Capital with participation from City Hill Ventures, Colt Ventures, JMCR Partners and HighLight Capital... |
| Apr 20, 2017 | Bonti Raises $11.7M Series B | NEWPORT BEACH, CA, Clinical-stage biotechnology company, today announced it successfully secured $11.7 million in a Series B financing. >> Click here for more funding data on Bonti >> To export Bonti funding data to PDF and ... |
| Apr 19, 2017 | Term Sheet — Wednesday, April 19 | M&A ACTION Mega M&A: Verizon hasn’t exactly been on the sidelines when it comes to splashy M&A (Yahoo, AOL, Vessel, Fleetmatics…), but CEO Lowell McAdam may still be itching for something more. (Perhaps he hasn’t won enough awar... |
| Apr 19, 2017 | Bonti Gets $11.7M For Aesthetic Medicine Efforts | Newport Beach-based Bonti, a biotechnology company which is developing a botulinum neurotoxin aimed at the aesthetic medicine market, has raised $11.7M in a Series B financing round. Bonti said the Series B funding was led by RBV Capital, a... |
Reviews 0
FAQ about AbbVie
When was AbbVie founded?
AbbVie was founded in 2013.
How much funding has AbbVie raised?
AbbVie has raised $27.2M in total across 2 funding rounds.
What funding rounds has AbbVie raised?
Parsers VC lists 2 funding rounds of AbbVie, among them a Series B round of $11.7M on Apr 19, 2017.
What has the press written about AbbVie?
Parsers VC has collected 8 articles mentioning AbbVie, among them “Term Sheet — Thursday, January 25” (Jan 25, 2018) and “Bonti Raises $15.5M” (Jan 24, 2018).
Is AbbVie still active?
Yes, AbbVie is active; its latest activity on Parsers VC dates from Sep 21, 2018.